Menarini International Operations Luxembourg

CompanyLuxembourg

Menarini International Operations Luxembourg develops one asset, in phase 3, no development reported (Zofenopril in hypertension). Mostly small molecule; based in Luxembourg.

1
Asset
Furthest stage
Phase 3, no development reported
7
Trials
0
Signals

Pipeline

1
  • Zofenopril

    Inhibits angiotensin-converting enzyme, reducing angiotensin II production and lowering blood pressure.

    Phase 3, no development reported, Small molecule, hypertension

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials8
  • Similar companies6

Intelligence